Lista de obras -

Activity of Ceftaroline against Aerobic Gram-Positive and Gram-Negative Pathogens: Effect of Test Method Variability

artículo científico publicado en 2011

Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor

artículo científico publicado en 2003

Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile

artículo científico publicado en 2010

Bacteriology of human bite wound infections

artículo científico publicado en 2003

Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera

artículo científico publicado en 2005

Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens

artículo científico publicado en 2005

Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections

artículo científico publicado en 2006

Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobac

artículo científico publicado en 2005

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections

artículo científico publicado en 2002

Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates

artículo científico publicado en 2006

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria

artículo científico publicado en 2009

Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

artículo científico publicado en 2001

Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites

artículo científico publicado en 2002

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents

artículo científico publicado en 2006

General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam

artículo científico publicado en 2002

In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical Isolates

artículo científico publicado en 2003

In Vitro Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species ⬇️

artículo científico publicado el 30 de enero de 2012

In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis

artículo científico publicado en 2003

In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis

artículo científico publicado en 2002

In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens

artículo científico publicado en 2002

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections

artículo científico publicado en 2006

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

artículo científico publicado en 2003

In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes

artículo científico publicado en 2006

In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates

artículo científico publicado en 2003

In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds

artículo científico publicado en 2007

In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species

artículo científico publicado en 2002

In vitro activities of iodonium salts against oral and dental anaerobes

artículo científico publicado en 2004

In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria

artículo científico publicado en 2003

In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis

artículo científico publicado en 2003

In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

artículo científico publicado en 2002

In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp

artículo científico publicado en 2004

In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis

artículo científico publicado en 2005

In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections

artículo científico publicado en 2005

In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens

scientific article published on 27 July 2006

In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections

artículo científico publicado en 2006

In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis

artículo científico publicado en 2002

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections

artículo científico publicado en 2006

Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods ⬇️

artículo científico publicado el 20 de abril de 2011

Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems

artículo científico publicado en 2000

Synergistes group organisms of human origin

artículo científico publicado en 2006

Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus

artículo científico publicado en 2008

Lista de obras de

Activity of Ceftaroline against Aerobic Gram-Positive and Gram-Negative Pathogens: Effect of Test Method Variability

Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor

Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile

Bacteriology of human bite wound infections

Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera

Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens

Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections

Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobac

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections

Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria

Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents

General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam

In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical Isolates

In Vitro Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species ⬇️

In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis

In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis

In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes

In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates

In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds

In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species

In vitro activities of iodonium salts against oral and dental anaerobes

In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria

In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis

In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp

In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis

In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections

In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens

In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections

In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections

Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods ⬇️

Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems

Synergistes group organisms of human origin

Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus